Steven Elliott Feldon, MD, MBA | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
Healthcare Professionals

Steven Elliott Feldon, MD, MBA

Healthcare Professional
Director
Strong Flaum Eye Institute
210 Crittenden Blvd, Floor 3
Rochester, New York, United States

Steven Elliott Feldon is an internationally acclaimed clinical and basic scientist with a specialty in orbital disease and neuro-ophthalmology. In 2001, he was appointed Chair of the University of Rochester Department of Ophthalmology, and is now Director of the Flaum Eye Institute.

Dr. Feldon earned his medical degree from the Albert Einstein College of Medicine. He completed his residency at the Massachusetts Eye & Ear Infirmary, Harvard University, along with a research fellowship in neurosurgery at Massachusetts General Hospital, and a clinical fellowship in neuro-ophthalmology at the University of California Medical Center, San Francisco.

Devoted to patient care, Dr. Feldon’s special interest is in the management of patients with thyroid-associated eye disease. Cranial nerve palsies, disorders of the optic nerve, visual field loss, and eye movement problems are all his specialty areas. Now leading a world-class team of eye care specialists, his clinical expertise has been recognized in “Best Doctors in America.” 

An inventor of ophthalmic instruments and a scientific investigator, Dr. Feldon is involved in a number of local and national clinical trials and basic science collaborations. He is the former President of the North American Neuro-Ophthalmic Society and the current Executive Vice President of the Association of University Professors of Ophthalmology. 

 

Representative Publications:

Axial Globe Position Measurement: A Prospective Multicenter Study by the International Thyroid Eye Disease Society

Retinal and Choroidal Folds in Papilledema

Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results

Graves’ Ophthalmopathy: III. Effect of Transantral Orbital Decompression on Optic Neuropathy